Liver Cancer

Hepatocellular Carcinoma

Female, 75 years

Patient Internal ID: 1520837976

ICD-10 code

C22.0 Liver Cell Carcinoma

Diagnosis (Incl. Metastases/Stage) and Year

March 2023
Hepatocellular Carcinoma cT4N2Mx with local nodular disease in the Porta Hepatis

Previous Treatment

The patient did not receive any treatment due to her poor health condition.

Prognosis and Survival Expectation

The prognosis for untreated HCC remains very poor, with a median survival of ~4 months from diagnosis.

Treatment Provided

Allogeneic Umbilical Cord Blood Derived NK Cells (4 doses) over a period of 1 month.

Patient Survival/Condition and Year
Date of Review: 23/01/2024

The patient receives palliative care, she has survived for 10 months since the diagnosis. It can be concluded that the addition of Immunotherapy has extended patient survival by an estimate of around 6 months so far.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok